NASDAQ: CLOEClover Leaf Capital Corp Stock
$12.00+0.00 (+0%)
Updated Apr 25, 2024
CLOE Price
$12.00
Fair Value Price
-$0.64
Market Cap
$63.85M
52 Week Low
$10.99
52 Week High
$12.50
P/E
-66.67x
P/B
-6.67x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$1.05M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
-$1M
Beta
0.03
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CLOE Overview
Clover Leaf Capital Corp. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, stock purchases, recapitalizations, reorganizations, or related business combinations. It targets the legalized cannabis industry. Clover Leaf Capital Corp is sponsored by Yntegra Capital Investments, LLC. The companyl was incorporated in 2021 and is based in Miami, FL.
Zen Score
–
Industry Average (8)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CLOE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CLOE ($12.00) is overvalued by 1,968.58% relative to our estimate of its Fair Value price of -$0.64 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CLOE ($12.00) is not significantly undervalued (1,968.58%) relative to our estimate of its Fair Value price of -$0.64 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CLOE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CLOE due diligence checks available for Premium users.
Be the first to know about important CLOE news, forecast changes, insider trades & much more!
CLOE News
Valuation
CLOE fair value
Fair Value of CLOE stock based on Discounted Cash Flow (DCF)
Price
$12.00
Fair Value
-$0.64
Undervalued by
1,968.58%
CLOE ($12.00) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CLOE ($12.00) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CLOE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CLOE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-66.67x
Industry
31.97x
Market
40.97x
CLOE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-6.67x
Industry
-14.36x
CLOE's financial health
Profit margin
Revenue
$0.0
Net Income
-$245.7k
Profit Margin
0%
CLOE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$14.9M
Liabilities
$9.7M
Debt to equity
-1.01
CLOE's short-term liabilities ($4.84M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLOE's long-term liabilities ($4.84M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLOE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLOE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$185.6k
Investing
-$180.0k
Financing
$515.0k
CLOE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CLOE vs Shell Company Stocks
Clover Leaf Capital Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.